We are live on ! Find out more
TELA icon

TELA Bio

45 hedge funds and large institutions have $19.3M invested in TELA Bio in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

22% more funds holding

Funds holding: 37 → 45 (+8)

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.55% less ownership

Funds ownership: 60.07% → 57.52% (-2.6%)

50% less capital inflows, than outflows

Capital inflows: $913K | Capital outflows: $1.83M

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
45
Holders Change
+8
Holders Change %
+21.62%
% of All Funds
0.54%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
9
Increased
12
Reduced
10
Closed
1
Calls
–
Puts
$1​K
Net Calls
-⁠$1​K
Net Calls Change
-⁠$465​K

TELA Hedge Fund Activity: Q2 2026 in Review

45 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2026, worth a combined $19.3M — up 16% from $16.7M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TELA positions and 1 closed out — a net gain of 8 holders — while 12 added to existing stakes and 10 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $614K. The largest seller was UBS Group, cutting an estimated $839K.

  • 45 institutional investors held TELA Bio (TELA) as of Q2 2026, up from 37 in Q1 2026.
  • Funds reported $19.3M of TELA Bio stock for Q2 2026, up 16% quarter-over-quarter.
  • 9 funds opened new TELA Bio positions in Q2 2026 and 1 closed out, a net change of +8 holders.
  • The largest TELA Bio buyer in Q2 2026 was Nantahala Capital Management, an estimated $614K added.
  • The largest TELA Bio seller in Q2 2026 was UBS Group, an estimated $839K sold.

Based on aggregated 13F filings for Q2 2026.